Data from the analytical performance of the Abaxis Piccolo Xpress point of care analyzer in whole blood, serum, and plasma

Kazunori Murata; Laurel Glaser; Mary Nardiello; Lakshmi V Ramanathan; Dean C Carlow

doi:10.1016/j.dib.2017.11.006

Data from the analytical performance of the Abaxis Piccolo Xpress point of care analyzer in whole blood, serum, and plasma

Data Brief. 2017 Nov 4:16:81-89. doi: 10.1016/j.dib.2017.11.006. eCollection 2018 Feb.

Authors

Kazunori Murata¹, Laurel Glaser², Mary Nardiello³, Lakshmi V Ramanathan¹, Dean C Carlow¹

Affiliations

¹ Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA.
² Department of Pathology and Laboratory Medicine, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA.
³ Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, USA.

Abstract

The objective of this study was to examine the analytical performance of 14 comprehensive metabolic panel analytes on the Abaxis Piccolo Xpress® Point of Care analyzer in serum, plasma, and whole blood. A method comparison was performed on all three specimen types intended for use on the Piccolo Xpress®: serum, heparinized plasma, and whole blood. This data is also presented in Murata et al. (2015) [1]. This article includes the actual Bland-Altman bias plots of the difference in results obtained for analytes in the comprehensive metabolic panel from the Abaxis Piccolo Xpress and the comparison instrument, the Ortho Vitros.

Keywords: Clinical chemistry; Point-of care testing.

Grants and funding

P30 CA008748/CA/NCI NIH HHS/United States